However, several other studies reported contrasting findings, indicating that only the more mature CD19+ B-ALL cells were capable of engrafting as both CD34+/CD38−/CD19+ and the CD34+/CD38+/CD19+ B-ALL cell populations could engraft B-ALL [125,126]. Here, CD19 is linked to acute lymphoblastic leukemia.